These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26218619)

  • 21. [Effect of the violation of normality and sphericity in the linear mixed model in split-plot designs].
    Arnau J; Bendayan R; Blanca MJ; Bono R
    Psicothema; 2012; 24(3):449-54. PubMed ID: 22748739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monte Carlo simulation of OLS and linear mixed model inference of phenotypic effects on gene expression.
    Walker JA
    PeerJ; 2016; 4():e2575. PubMed ID: 27761350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propagation of uncertainty in nasal spray in vitro performance models using Monte Carlo simulation: Part II. Error propagation during product performance modeling.
    Guo C; Doub WH; Kauffman JF
    J Pharm Sci; 2010 Aug; 99(8):3572-8. PubMed ID: 20564385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type I error control for cluster randomized trials under varying small sample structures.
    Nugent JR; Kleinman KP
    BMC Med Res Methodol; 2021 Apr; 21(1):65. PubMed ID: 33812367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing a single case with a control sample: refinements and extensions.
    Corballis MC
    Neuropsychologia; 2009 Nov; 47(13):2687-9. PubMed ID: 19383504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting dissociations in single-case studies: Type I errors, statistical power and the classical versus strong distinction.
    Crawford JR; Garthwaite PH
    Neuropsychologia; 2006; 44(12):2249-58. PubMed ID: 16820178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring explained variation in linear mixed effects models.
    Xu R
    Stat Med; 2003 Nov; 22(22):3527-41. PubMed ID: 14601017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sample size computations for PK/PD population models.
    Kang D; Schwartz JB; Verotta D
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):685-701. PubMed ID: 16284914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of multinomial and binomial proportion methods for analysis of multinomial count data.
    Galyean ML; Wester DB
    J Anim Sci; 2010 Oct; 88(10):3452-63. PubMed ID: 20601524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical models for autocorrelated count data.
    Nelson KP; Leroux BG
    Stat Med; 2006 Apr; 25(8):1413-30. PubMed ID: 16196078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I and Type II error under random-effects misspecification in generalized linear mixed models.
    Litière S; Alonso A; Molenberghs G
    Biometrics; 2007 Dec; 63(4):1038-44. PubMed ID: 17425642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Power equivalence in structural equation modelling.
    von Oertzen T
    Br J Math Stat Psychol; 2010 May; 63(Pt 2):257-72. PubMed ID: 19527562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inferential methods for comparing two single cases.
    Crawford JR; Garthwaite PH; Wood LT
    Cogn Neuropsychol; 2010 Jul; 27(5):377-400. PubMed ID: 21718213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-individual measures of association in neuropsychology: inferential methods for comparing a single case with a control or normative sample.
    Crawford JR; Garthwaite PH; Howell DC; Venneri A
    J Int Neuropsychol Soc; 2003 Nov; 9(7):989-1000. PubMed ID: 14738281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Power and sample size for the S:T repeated measures design combined with a linear mixed-effects model allowing for missing data.
    Tango T
    J Biopharm Stat; 2017; 27(6):963-974. PubMed ID: 28319460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
    Dallow NS; Leonov SL; Roger JH
    Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of permutation and mixed-model regression methods for the analysis of simulated data in the context of a group-randomized trial.
    Murray DM; Hannan PJ; Pals SP; McCowen RG; Baker WL; Blitstein JL
    Stat Med; 2006 Feb; 25(3):375-88. PubMed ID: 16143991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing dependent correlations.
    Wilcox RR; Tian T
    J Gen Psychol; 2008 Jan; 135(1):105-12. PubMed ID: 18318411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating a positive false discovery rate for variable selection in pharmacogenetic studies.
    Li L; Hui S; Pennello G; Desta Z; Todd S; Nguyen A; Flockhart D
    J Biopharm Stat; 2007; 17(5):883-902. PubMed ID: 17885872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.